KNOBELMAN DEBORAH
Known title: Chief Financial OfficerCIK: 0001931509
Associated companies
Transaction History
| SNTI | ▲ Buy | Grant | 101,000 | $0 | 2/1/2024 | View on chart |
| SNTI | ▲ Buy | Grant | 30,000 | $0 | 10/3/2022 | View on chart |
| SNTI | ▲ Buy | Grant | 101,000 | $0 | 2/1/2024 | View on chart |
| SNTI | ▲ Buy | Grant | 30,000 | $0 | 10/3/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
SNTI Included in List of Health Care Stocks Moving Pre-Market
Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.
SNTI Included in List of Health Care Stocks Moving Pre-Market. Senti Biosciences was named in a Benzinga report listing 12 health care stocks showing movement during Tuesday's pre-market session. The stock is currently trading within a wide 52-week range of $0.29 to $2.88. This inclusion highlights short-term trading activity rather than a specific fundamental change.